prednisone has been researched along with amifampridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jost, WH; Mielke, U; Schimrigk, K | 1 |
| Bramanti, A; Bramanti, P; Brizzi, T; Cacciola, A; De Cola, MC; Lupica, A; Milardi, D; Portaro, S; Rodolico, C; Sinicropi, S; Toscano, A | 1 |
| Gandhy, S; Gill, AJ; Lancaster, E | 1 |
3 other study(ies) available for prednisone and amifampridine
| Article | Year |
|---|---|
Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
Topics: 4-Aminopyridine; Amifampridine; Combined Modality Therapy; Electromyography; Follow-Up Studies; Guanidine; Guanidines; Humans; Lambert-Eaton Myasthenic Syndrome; Long-Term Care; Male; Neurologic Examination; Plasmapheresis; Prednisone | 1991 |
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports.
Topics: 4-Aminopyridine; Activities of Daily Living; Adult; Amifampridine; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lambert-Eaton Myasthenic Syndrome; Male; Middle Aged; Muscle Strength; Prednisone; Severity of Illness Index; Treatment Outcome | 2017 |
Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumor.
Topics: Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Calcium Channels, P-Type; Calcium Channels, Q-Type; Cerebellar Diseases; Cerebellar Neoplasms; Female; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Immunoglobulins, Intravenous; Immunologic Factors; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Nerve Degeneration; Neuroendocrine Tumors; Neuromuscular Agents; Nivolumab; Positron Emission Tomography Computed Tomography; Prednisone; Radiosurgery; Radiotherapy; Rituximab; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2021 |